Breakthrough Drug Prices Will Be “Huge” Policy Issue; IoM Plans Forum
Executive Summary
The next frontier in the debate over drug pricing will be the cost of highly effective breakthrough drugs, CMS Chief Medical Officer Sean Tunis, MD, predicted during the Biotechnology Industry Organization annual meeting in San Francisco June 7